Fischer Medical Ventures Limited has submitted a regulatory disclosure to BSE Limited and the National Stock Exchange of India Ltd. pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The disclosure intimates that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 14th August 2026. The meeting will be conducted through video conferencing.
The agenda for the board meeting includes:
- To consider and take on record the unaudited standalone financial results of the company for the quarter ended 30th June 2026
- To consider and take on record the unaudited consolidated financial results of the company for the quarter ended 30th June 2026
- To transact any other matter as may be specified in the agenda
The company confirms that the trading window for dealing in the equity shares of the Company is already closed for all designated persons, their immediate relatives, and other connected persons. This closure was previously communicated via letter dated 30th June 2026. The trading window shall remain closed until 48 hours after the declaration of the financial results for the quarter ended 30th June 2026.
The disclosure was signed by Balaji Gandla, Company Secretary & Compliance Officer, on 7th August 2026 at 17:30:50 IST.